Mundipharma International Ltd:企業の戦略的SWOT分析

◆英語タイトル:Mundipharma International Ltd - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2572
◆発行会社(調査会社):GlobalData
◆発行日:2020年2月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Mundipharma International Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Mundipharma International Ltd (Mundipharma) conducts research and develops products for the treatment pain management, respiratory, cancer and inflammatory conditions. The company commercializes and launches products within Europe and rest of the world. Mundipharma offers products through network of subsidiaries, independent associated companies, partners and joint ventures. The company’s network includes Napp Pharmaceuticals, Norpharma and the Mundipharma independent associated companies. The company provides its services to patients, healthcare professionals and health systems worldwide. It has operations in Australia, Japan, New Zealand, Russia, Singapore, Philippines, South Africa, South Korea, Canada, China and USA. Mundipharma is headquartered in Cambridge, the UK.

Mundipharma International Ltd Key Recent Developments

Sep 04,2019: Cidara and Mundipharma sign rezafungin drug development deal
Jun 14,2019: Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets
Feb 18,2019: Mundipharma appoints Patrice Grand as European Director of Corporate Communications

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Mundipharma International Ltd – Key Facts
Mundipharma International Ltd – Key Employees
Mundipharma International Ltd – Key Employee Biographies
Mundipharma International Ltd – Major Products and Services
Mundipharma International Ltd – History
Mundipharma International Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Mundipharma International Ltd – Business Description
Mundipharma International Ltd – Corporate Strategy
Mundipharma International Ltd – SWOT Analysis
SWOT Analysis – Overview
Mundipharma International Ltd – Strengths
Mundipharma International Ltd – Weaknesses
Mundipharma International Ltd – Opportunities
Mundipharma International Ltd – Threats
Mundipharma International Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Mundipharma International Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Sep 04, 2019: Cidara and Mundipharma sign rezafungin drug development deal
Jun 14, 2019: Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets
Feb 18, 2019: Mundipharma appoints Patrice Grand as European Director of Corporate Communications
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Mundipharma International Ltd, Key Facts
Mundipharma International Ltd, Key Employees
Mundipharma International Ltd, Key Employee Biographies
Mundipharma International Ltd, Major Products and Services
Mundipharma International Ltd, History
Mundipharma International Ltd, Subsidiaries
Mundipharma International Ltd, Joint Venture
Mundipharma International Ltd, Key Competitors
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Mundipharma International Ltd, Recent Deals Summary

List of Figures
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Mundipharma International Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BlackRock Inc:戦略・SWOT・企業財務分析
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • American Express Company:企業のM&A・事業提携・投資動向
    American Express Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American Express Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Cavium Inc:企業の戦略的SWOT分析
    Cavium Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Wellington Pub Company PLC:企業の戦略・SWOT・財務情報
    Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report Summary Wellington Pub Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • U.S. HealthWorks Medical Group:企業のM&A・事業提携・投資動向
    U.S. HealthWorks Medical Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's U.S. HealthWorks Medical Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • The Empire District Electric Co:電力:M&Aディール及び事業提携情報
    Summary The Empire District Electric Co (EDE), a subsidiary of Liberty Utilities Co, is a regulated utility that provides electricity, natural gas, and water services. The company generates, procures, transmits, distributes, and sells electricity. It generates electricity from natural gas, coal, and …
  • Guaranty Trust Bank Plc:企業の戦略・SWOT・財務情報
    Guaranty Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Guaranty Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Gemdale Corporation:企業の戦略・SWOT・財務分析
    Gemdale Corporation - Strategy, SWOT and Corporate Finance Report Summary Gemdale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Austin Exploration Limited (AKK)-石油・ガス分野:企業M&A・提携分析
    Summary Austin Exploration Limited (Austin) is upstream oil and gas company that acquires, explores, develops, and produces oil and natural gas in the US. The company holds working interests in Colorado in the DJ Basin with the Niobrara and Pierre Shale as its primary oil and gas formations. It also …
  • Belize Electricity Ltd:企業の発電所・SWOT分析2018
    Belize Electricity Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務分析
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Marriott Vacations Worldwide Corp:企業の戦略・SWOT・財務分析
    Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PT MultiIntegra:企業の戦略・SWOT・財務情報
    PT MultiIntegra - Strategy, SWOT and Corporate Finance Report Summary PT MultiIntegra - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ZIL Limited:企業の戦略・SWOT・財務情報
    ZIL Limited - Strategy, SWOT and Corporate Finance Report Summary ZIL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • WellSky Corp:企業の戦略的SWOT分析
    WellSky Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Synmosa Biopharma Corp (4114):製薬・医療:M&Aディール及び事業提携情報
    Summary Synmosa Biopharma Corp (Synmosa) is a pharmaceutical company that manufactures, markets and distributes generic medicines. The company produces non-pharmaceutical products such as cosmeceutical and nutrition products, and food supplements in effervescent tablet and granule forms. It offers p …
  • HealthCare Global Enterprises Ltd (HCG)-製薬・医療分野:企業M&A・提携分析
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that offers medical care and treatment services. The company offers services such as clinical laboratory services, diagnosis services, medical oncology services, radiation …
  • Cabot Energy Plc (CAB):石油・ガス:M&Aディール及び事業提携情報
    Summary Cabot Energy Plc (Cabot), formerly Northern Petroleum, is an independent upstream oil and gas company. It explores for, develops, and produces oil and natural gas; and trades assets. The company operates in onshore and offshore projects including gas producing fields and oil fields. Cabot's …
  • Meezan Bank Ltd:企業の戦略・SWOT・財務情報
    Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆